Patent 7514470 was granted and assigned to Smithkline Beecham Limited on April, 2009 by the United States Patent and Trademark Office.
This invention relates to non-steroidal compounds that are modulators of androgen, glucocorticoid, mineralocorticoid, and progesterone receptors, and also to the methods for the making and use of such compounds.